RICHTECH ROBOTICS INC.
For the period ended Sep 30, 2025. Filed Jan 20, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jan 20, 2026
RR$0.95+6.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
RICHTECH ROBOTICS, INC.
Consolidated Statements of Cash Flows
For the year ended September 30, 2025 and 2024
(In thousands)
| 2025 | 2024 | |
|---|---|---|
| Cash flows from operating Activities: | ||
| Net loss | $(15,754) | $(8,140) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Accounts receivable | (421) | 4,218 |
| Inventory | (232) | (326) |
| Prepaid expenses and other current assets | (396) | (16) |
| Right-of-use asset | (225) | (191) |
| Accounts payable | 247 | (976) |
| Deferred revenue | 248 | - |
| Tax payable | 50 | (456) |
| Accrued expenses and other payable | 1,280 | 38 |
| Deferred Tax assets | - | 518 |
| Depreciation and amortization | 2,319 | 81 |
| Stock based compensation | 3,724 | - |
| Non-Operating Losses | (108) | - |
| Operating lease liabilities, current | 152 | (12) |
| Operating lease liabilities, non- current | 73 | 202 |
| Net cash provided by operating activities | (9,043) | (5,060) |
| Cash flows from investing activities: | ||
| Purchase of PPE | (5,009) | (725) |
| Purchase of intangible assets | (591) | (5,470) |
| Purchase of short-term investments | (41,975) | (15,940) |
| Purchase of long-term investments | 102 | (730) |
| Notes receivable | (523) | - |
| Cash used for lending to related parties | - | 134 |
| Net cash used in investing activities | (47,996) | (22,731) |
| Cash flows from financing activities: | ||
| Payment of loans received from third parties | (53) | (3,792) |
| Contributions from Non-controlling Interests | 65 | - |
| Proceeds from warrants exercise | 16,266 | - |
| Loans received from third parties | 16 | 3,102 |
| Loan settlement | - | 3,383 |
| Payment of related party debt | - | (238) |
| Proceeds from issuance of ordinary shares | 219,808 | 30,182 |
| Proceeds from stockholder capital injection | - | 9,286 |
| Net Cash used in financing activities | 236,102 | 41,923 |
| Net change in cash and cash equivalents | 179,063 | 14,132 |
| Cash, cash equivalents and restricted cash at beginning of the period | $14,566 | $433 |
| Cash, cash equivalents and restricted cash at end of the period | $193,629 | $14,566 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.